62.4 F
New York
Tuesday, December 1, 2020

Will the CV Sciences Inc (OTCMKTS:CVSI) Train Keep Steaming Along?

Must read

British American Tobacco p.l.c. (NYSE:BTI) Recent Earnings Shows Major Promise

British American Tobacco p.l.c. (BTI) shares are trading at higher $35.85 and the avg recommendation for the stock is Strong Buy, while the current...

The Alkaline Water Company Inc. (NASDAQ:WTER) is Waving the Bull Flag

The Alkaline Water Company Inc. (WTER) shares are trading at higher $1.19 and the avg recommendation for the stock is Moderate Buy. To add...

Pennsylvania Real Estate Investment Trust (NYSE:PEI) is Gaining Momentum on Earnings Catalyst

Pennsylvania Real Estate Investment Trust (PEI) shares are trading at higher $1.14 and the avg recommendation for the stock is Hold, while the current...

Daqo New Energy Corp. (NYSE:DQ) Stock is Soaring, Here is Why

Daqo New Energy Corp. (DQ) shares are trading at higher $45.26 and the avg recommendation for the stock is Strong Buy, while the current...

Shares of CV Sciences Inc (OTCMKTS:CVSI) have been in powerful momentum mode over the past 6 months, powering about 450% higher in that time. And the action is paying itself off in the form of improving fundamental performance and an open application to uplist onto a big board exchange. As for the company’s execution, its most recent release tells a strong story.

“Q2 2018 was a pivotal quarter for the Company, as it validates our continued momentum in driving growth and sales,” stated Joseph Dowling, Chief Executive Officer (CEO) of CV Sciences. “In Q1 of 2018, we reported our first quarter of profitability, and with these Q2 results we have demonstrated the strength of our products and the power of our brand recognition within the industry. Our PlusCBD™ product line is now positioned for mainstream acceptance and expanded distribution as the health and wellness markets continue to embrace CBD commercialization and standardization.”

CV Sciences Inc (OTCMKTS:CVSI) frames itself as a life science company, focuses on developing and commercializing novel therapeutics utilizing synthetic Cannabidiol (CBD).

CVSI operates two distinct business segments: a drug development division focused on developing and commercializing novel therapeutics utilizing synthetic CBD; and, a consumer product division in manufacturing, marketing and selling plant-based CBD products to a range of market sectors, including nutraceutical, beauty care, specialty foods, and vape.

Following the CanX Acquisition in December 2015, CV Sciences commenced its preclinical drug development program during the second quarter of 2016. The Company’s drug development efforts include pursuing synthetic-based Cannabidiol drug candidates in areas that have the potential to provide significant improvements in therapeutic patient treatments with sizable addressable markets.

The company was formerly known as CannaVEST Corp. and changed its name to CV Sciences, Inc. in January 2016. CV Sciences, Inc. has primary offices and facilities in Las Vegas, Nevada and San Diego, California.

CV Sciences Inc is led by Michael J. Mona, JR. founder of CV Sciences, Mr. Mona possesses over 30 years of senior management experience in a range of industries including real estate/construction, industrial farming, chemical processing and consumer products. Mr. Mona is a recognized industry leader in hemp farming operations and chemical extraction and has established a global supply chain of hemp-derived products.

According to company materials, “CV Sciences, Inc. (CVSI) operates two distinct business segments: a drug development division focused on developing and commercializing novel therapeutics utilizing synthetic CBD; and, a consumer product division in manufacturing, marketing and selling plant-based CBD products to a range of market sectors. CV Sciences, Inc. has primary offices and facilities in Las Vegas, Nevada and San Diego, California.”

Find out when $CVSI stock reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.

We’ve witnessed 61% piled on for shareholders of the company during the trailing month. Moreover, the stock has seen a growing influx of trading interest, with the stock’s recent average trading volume running nearly 140% beyond its prior sustained average level.

According to the release, “Second quarter 2018 revenue is expected to be $12.3 million, up 203% compared to the second quarter of 2017, and a 53% sequential increase over Q1 2018. The company increased retail store count to 1,968 natural and organic health food stores as of June 30, 2018, representing an 11.1% sequential increase over the Company’s retail store count for the first quarter of 2018.”

Currently trading at a market capitalization of $248.3M, CVSI has a significant war chest ($3.9M) of cash on the books, which stands against about $390K in total current liabilities. CVSI is pulling in trailing 12-month revenues of $25M. In addition, the company is seeing major top-line growth, with y/y quarterly revenues growing at 114.4%. This may be a very interesting story and we will look forward to updating it again soon. Sign-up for continuing coverage on shares of $CVSI stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!

Disclosure: we hold no position in $CVSI, either long or short, and we have not been compensated for this article.

Latest article

ToughBuilt Industries Inc. (NASDAQ:TBLT) Stock is Soaring, Here is Why

ToughBuilt Industries Inc. (TBLT) shares are trading at higher $0.83 and the avg recommendation for the stock is Moderate Buy. To add more color...

3M Company (MMM)’s Stock is Jumping, Here is Why

3M Company (MMM) shares are trading at lower $176.89 and the avg recommendation for the stock is Hold, while the current analyst price target...

Can We Expect More Volatility From Novo Nordisk A/S (NVO)?

Novo Nordisk A/S (NVO) shares are trading at higher $67.54 and the avg recommendation for the stock is Hold, while the current analyst price...

When Will Urban One Inc. (UONEK) Slow Down

Urban One Inc. (UONEK) shares are trading at higher $1.41. To add more color to this target, the company’s high over the last year...

Nordic American Tankers Limited (NYSE:NAT) is Gaining Momentum on Earnings Catalyst

Nordic American Tankers Limited (NAT) shares are trading at lower $3.32 and the avg recommendation for the stock is Moderate Buy. To add more...